Microorganisms isolated from the corneal surface before and during topical cyclosporine treatment in dogs with keratoconjunctivitis sicca.
The effect that topical administration of cyclosporine would have on the number and type of microorganisms isolated from the corneal surface of dogs with keratoconjunctivitis sicca was studied. Schirmer tear test wear performed on and corneal swab specimens were collected from 61 eyes of 31 dogs with keratoconjunctivitis sicca prior to and after 3, 6, and 12 months of treatment with cyclosporine. In eyes that responded to cyclosporine treatment (Schirmer tear test value increased by > or = 5 mm/min, compared with pretreatment value), the percentage of eyes from which bacteria were isolated 3, 6, and 12 months of treatment was significantly (P < 0.001) less than the percentage from which bacteria were isolated prior to treatment. However, among eyes that did not respond to treatment, we did not detect a significant change over time in prevalence of bacteria or type of bacteria isolated. The percentage of eyes from which fungi were isolated decreased during treatment; however, the small number of eyes in which fungal culture results were initially positive precluded demonstration of a significant differences over time in the frequency with which specific bacterial genera were isolated, with the exception of beta-hemolytic Streptococcus spp. Opportunistic corneal infections were not detected even though none of the dogs received antibiotics. An increase in production of tears, which contain anti-infection, proteins, was believed to be the primary factor responsible for the decrease in the percentage of eyes from which microorganisms could be isolated.
Salisbury
M A
MA
Department of Small Animal Medicine, College of Veterinary Medicine, University of Georgia, Athens 30602, USA.
Kaswan
R L
RL
Brown
J
J
D000818:Animals; D001419:Bacteria / Q000302:isolation & purification*; D003315:Cornea / Q000382:microbiology*; D016572:Cyclosporine / Q000627:therapeutic use*; D004283:Dog Diseases; D004285:Dogs; D005658:Fungi / Q000302:isolation & purification; D007638:Keratoconjunctivitis Sicca / Q000188:drug therapy / Q000382:microbiology / Q000662:veterinary*; D009894:Opportunistic Infections / Q000382:microbiology / Q000662:veterinary; D012016:Reference Values; D013210:Staphylococcus / Q000302:isolation & purification; D013291:Streptococcus / Q000302:isolation & purification
D016572:Cyclosporine